Medicine

Effect of Celiprolol on Prevention of Cardiovascular Events in Vascular Ehlers-Danlos Syndrome

K. Ong, J. Perdu, H. Plauchu, J. D. Backer, A. Paepe, J. Emmerich, X. Jeunemaître, D. Germain, P. Collignon, G. Georgesco, E. Bozec, J. Hulot, S. Laurent, P. Boutouyrie

2009.12.1Artery Research

DOI: 10.1016/j.artres.2009.10.154

tlooto Summary

Celiprolol might be the treatment of choice for physicians aiming to prevent major complications in patients with vascular Ehlers-Danlos syndrome and whether patients with similar clinical presentations and no mutation are also protected remains to be established.

Abstract

Abstract is not available.

Citation format

ONG, K., et al. Effect of celiprolol on prevention of cardiovascular events in vascular ehlers-danlos syndrome. Artery Research, 2009, 3: 153–154.